CUE

Cue Biopharma Stock Analysis

AI Rating

Fair
  • Quality1/10
  • Growth↑ 7/10
  • Value↓ 0/10
Cue Biopharma sales and earnings growth
CUE Growth
Good
  • Revenue Y/Y↑ 195.75%
  • EPS Y/Y↑ 61.11%
  • FCF Y/Y↑ 39.87%
Cue Biopharma gross and profit margin trends
CUE Profitability
Neutral
  • Gross margin ↑ 100.00%
  • EPS margin↓ -96.90%
  • ROIC 5Y↓ -842.75%
Cue Biopharma net debt vs free cash flow
CUE Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -72.1

Cue Biopharma stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks